eCite Digital Repository
Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours
Citation
FitzGerald, LM and Raspin, K and Marthick, JR and Field, MA and Malley, RC and Thomson, RJ and Blackburn, NB and Banks, A and Charlesworth, JC and Donovan, S and Dickinson, JL, Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours, Scientific Reports, 7, (1) Article 17778. ISSN 2045-2322 (2017) [Refereed Article]
 | PDF 1Mb |
Copyright Statement
Copyright 2017 the authors. Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/
DOI: doi:10.1038/s41598-017-18217-w
Abstract
The HOXB13 G84E variant is associated with risk of prostate cancer (PCa), however the role this variant plays in PCa development is unknown. This study examined 751 cases, 450 relatives and 355 controls to determine the contribution of this variant to PCa risk in Tasmania and investigated HOXB13 gene and protein expression in tumours from nine G84E heterozygote variant and 13 wild-type carriers. Quantitative PCR and immunohistochemistry showed that HOXB13 gene and protein expression did not differ between tumour samples from variant and wild-type carriers. Allele-specific transcription revealed that two of seven G84E carriers transcribed both the variant and wild-type allele, while five carriers transcribed the wild-type allele. Methylation of surrounding CpG sites was lower in the variant compared to the wild-type allele, however overall methylation across the region was very low. Notably, tumour characteristics were less aggressive in the two variant carriers that transcribed the variant allele compared to the five that did not. This study has shown that HOXB13 expression does not differ between tumour tissue of G84E variant carriers and non-carriers. Intriguingly, the G84E variant allele was rarely transcribed in carriers, suggesting that HOXB13 expression may be driven by the wild-type allele in the majority of carriers.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | prostate cancer, HOXB13, gene expression, protein expression |
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Oncology and carcinogenesis |
| Research Field: | Cancer genetics |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Clinical health not elsewhere classified |
| UTAS Author: | FitzGerald, LM (Dr Liesel Fitzgerald) |
| UTAS Author: | Raspin, K (Ms Kelsie Raspin) |
| UTAS Author: | Marthick, JR (Mr James Marthick) |
| UTAS Author: | Malley, RC (Dr Roslyn Malley) |
| UTAS Author: | Blackburn, NB (Mr Nicholas Blackburn) |
| UTAS Author: | Banks, A (Mrs Annette Banks) |
| UTAS Author: | Charlesworth, JC (Dr Jac Charlesworth) |
| UTAS Author: | Dickinson, JL (Professor Joanne Dickinson) |
| ID Code: | 123541 |
| Year Published: | 2017 |
| Web of Science® Times Cited: | 3 |
| Deposited By: | Menzies Institute for Medical Research |
| Deposited On: | 2018-01-11 |
| Last Modified: | 2018-07-23 |
| Downloads: | 100 View Download Statistics |
Repository Staff Only: item control page